Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1982 2
1984 1
1985 3
1986 1
1987 3
1988 1
1989 1
1991 1
1993 3
1994 2
1995 1
1996 3
1997 8
1998 2
1999 3
2000 4
2002 3
2003 5
2004 2
2005 2
2006 9
2007 2
2008 5
2009 1
2010 3
2011 1
2012 4
2013 1
2014 3
2015 1
2016 1
2017 2
2018 2
2019 2
2020 10
2021 2
2022 2
2023 6
2024 11
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer.
Ray-Coquard I, Pautier P, Pignata S, Pérol D, González-Martín A, Berger R, Fujiwara K, Vergote I, Colombo N, Mäenpää J, Selle F, Sehouli J, Lorusso D, Guerra Alía EM, Reinthaller A, Nagao S, Lefeuvre-Plesse C, Canzler U, Scambia G, Lortholary A, Marmé F, Combe P, de Gregorio N, Rodrigues M, Buderath P, Dubot C, Burges A, You B, Pujade-Lauraine E, Harter P; PAOLA-1 Investigators. Ray-Coquard I, et al. N Engl J Med. 2019 Dec 19;381(25):2416-2428. doi: 10.1056/NEJMoa1911361. N Engl J Med. 2019. PMID: 31851799 Clinical Trial.
NGF/TrkA Signaling as a Therapeutic Target for Pain.
Hirose M, Kuroda Y, Murata E. Hirose M, et al. Among authors: murata e. Pain Pract. 2016 Feb;16(2):175-82. doi: 10.1111/papr.12342. Epub 2015 Aug 27. Pain Pract. 2016. PMID: 26452158 Review.
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Leman R, Muller E, Legros A, Goardon N, Chentli I, Atkinson A, Tranchant A, Castera L, Krieger S, Ricou A, Boulouard F, Joly F, Boucly R, Dumont A, Basset N, Coulet F, Chevalier LM, Rouleau E, Leitner K, González-Martin A, Gargiulo P, Lück HJ, Genestie C; PAOLA-1 investigators; Ray-Coquard I, Pujade-Lauraine E, Vaur D. Leman R, et al. Clin Cancer Res. 2023 Nov 1;29(21):4419-4429. doi: 10.1158/1078-0432.CCR-23-0898. Clin Cancer Res. 2023. PMID: 37756555 Free PMC article.
Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
Harter P, Marth C, Mouret-Reynier MA, Cropet C, Lorusso D, Guerra-Alía EM, Matsumoto T, Vergote I, Colombo N, Mäenpää J, Lebreton C, de Gregorio N, Mosconi AM, Rubio-Pérez MJ, Bourgeois H, Fasching PA, Cecere SC, Hardy-Bessard AC, Denschlag D, de Percin S, Hanker L, Favier L, Bauerschlag D, Desauw C, Hillemanns P, Largillier R, Sehouli J, Grenier J, Pujade-Lauraine E, Ray-Coquard I; PAOLA-1/ENGOT-ov25 investigators. Harter P, et al. Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.10.828. Online ahead of print. Ann Oncol. 2024. PMID: 39528049 Free article.
Impaired immunoproteasomal function exacerbates renal ischemia-reperfusion injury.
Ishii Y, Fukui-Miyazaki A, Iwasaki S, Tsuji T, Hotta K, Sasaki H, Nakagawa S, Yoshida T, Murata E, Taniguchi K, Shinohara N, Ishizu A, Kasahara M, Tomaru U. Ishii Y, et al. Among authors: murata e. Exp Mol Pathol. 2024 Dec;140:104939. doi: 10.1016/j.yexmp.2024.104939. Epub 2024 Oct 18. Exp Mol Pathol. 2024. PMID: 39426027 Free article.
The Burden of Burns: An Analysis of Public Health Measures.
Ivanko A, Garbuzov AE, Schoen JE, Kearns R, Phillips B, Murata E, Danos D, Phelan HA, Carter JE. Ivanko A, et al. Among authors: murata e. J Burn Care Res. 2024 Sep 6;45(5):1095-1097. doi: 10.1093/jbcr/irae053. J Burn Care Res. 2024. PMID: 38609187
111 results